HeLa cell transformants overproducing mouse metallothionein show in vivo resistance to cis-platinum in nude mice

Japanese Journal of Cancer Research

Volumn 91, Issue 1, 2000, Pages 91-98

  Toyoda, Haruka ^a,c   Mizushima, Tomoe ^a   Satoh, Masahiko ^a,d   Iizuka, Narushi ^b   Nomoto, Akio ^b,e   Chiba, Harumi ^a   Mita, Masaharu ^a   Naganuma, Akira ^a,f   Himeno, Seiichiro ^a   Imura, Nobumasa ^a  

^a KITASATO UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^c Japan Ministry of Health Labour and Welfare   (Japan)

^d NATIONAL INSTITUTE FOR ENVIRONMENTAL STUDIES   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

^f TOHOKU UNIVERSITY   (Japan)

Author keywords

cis platinum; Drug resistance; HeLa cell; Metallothionein; Overexpression

Indexed keywords

CADMIUM; CISPLATIN; COMPLEMENTARY DNA; METALLOTHIONEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CELL TRANSFORMATION; CONTROLLED STUDY; FEMALE; HELA CELL; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; NUDE MOUSE; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN SYNTHESIS; SIMIAN VIRUS 40;

EID: 0034052475     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2000.tb00864.x     Document Type: Article

References (46)

1. Rosenberg, R. C., Van Camp, L., Trosko, J. E. and Mansour, V. H. Platinum compounds: a new class of potent antitumor agents. Nature, 222, 385-386 (1969).
2. Krakoff, I. H. and Lippman, A. J. Clinical trials of cis-platinum diaminodichloride in patients with advanced cancer. In "Recent Results in Cancer Research," ed. G. Mathe and R. K. Old, pp. 185-193 (1974), Springer-Verlag, Berlin and New York.
3. Swelling, L. A. and Kohn, K. W. Mechanism of action of cis-dichlorodiammineplatinum (II). Cancer Treat. Rep., 63, 1439-1444 (1979).
4. Andrews, P. A. and Hoxell, S. B. Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance. Cancer Cells, 2, 35-43 (1990).
5. Andrews, P. A., Sriharasha, V., Mann, S. C. and Howell, S. B. Cis-diamminedichloroplatinum (II) accumulation in sensitive and resistant human ovarian carcinoma cells. Cancer Res., 48, 68-73 (1988).
6. Basu, A. and Lazo, J. S. A hypothesis regarding the protective role of metallothioneins against the toxicity of DNA interactive anticancer drugs. Toxicol. Lett., 50, 123-135 (1990).
7. Lazo, J. S. and Basu, A. Metallothionein expression and transient resistance to electrophilic antineoplastic drugs. Semin. Cancer Biol., 2, 267-271 (1991).
8. Masada, H., Ozols, R. E., Lai, G. M., Fojo, A., Rothenberg, M. and Hamilton, T. C. Increased DNA repair as a mechanism of acquired resistance to cis-diamminedichloroplatinum (II) in human ovarian cancer cell lines. Cancer Res., 48, 5713-5716 (1988).
9. Kägi, J. H. R. and Schaffer, A. Biochemistry of metallothionein. Biochemistry, 27, 8509-8515 (1988).
10. Endresen, L., Bakka, A. and Rugstad, H. E. Increased resistance to chlorambucil in cultured cells with a high concentration of cytoplasmic metallothionein. Cancer Res., 43, 2918-2926 (1983).
11. Cagen, S. Z., and Klaassen, C. D. Binding of glutathione-depleting agents to metallothionein. Toxicol. Appl. Pharmacol. 54, 229-237 (1980).
12. Thornally, P. J. and Vasak, M. Possible role for metallothionein in protection against radiation-induced oxidation stress. Kinetics and mechanism of its reaction with superoxide and hydroxyl radicals. Biochim. Biophys. Acta, 827, 36-44 (1985).
13. Abel, J. and Ruiter, N. Inhibition of hydroxy-radical generated DNA degradation by metallothionein. Toxicol. Lett., 47, 191-196 (1989).
14. Satoh, M., Naganuma, A. and Imura, N. Metallothionein induction prevents toxic side effects of cisplatin and adriamycin used in combination. Cancer Chemother. Pharmacol., 21, 176-178 (1988).
15. Naganuma, A., Satoh, M. and Imura, N. Prevention of lethal and renal toxicity of cis-diamminedichloroplatinum (II) by induction of metallothionein synthesis without compromising its antitumor activity in mice. Cancer Res., 47, 983-987 (1987).
16. Kondo, Y., Satoh, M., Imura, N. and Akimoto. M. Effect of bismuth nitrate given in combination with cis-diamminedichloroplatinum (II) on the antitumor activity and renal toxicity of the latter in nude mice inoculated with human bladder tumor. Cancer Chemother. Pharmacol., 29, 19-23 (1991).
17. Naganuma, A., Satoh, M. and Imura, N. Specific reduction of toxic side effects of adriamycin by induction of metallothionein in mice. Jpn. J. Cancer Res., 79, 406-411 (1988).
18. Satoh, M., Naganuma, A. and Imura, N. Involvement of cardiac metallothionein in prevention of adriamycin induced lipid peroxidation in the heart. Toxicology, 53, 231-237 (1988).
19. Satomi, N., Sakurai, A., Haranaka, R. and Haranaka, K. Preventive effect of several chemicals against lethality of recombinant human tumor necrosis factor. J. Biol. Response Mod., 7, 54-64 (1988).
20. Satoh, M., Miura, N., Naganuma, A., Matsuzaki, N., Kawamura, E. and Imura, N. Prevention of adverse effects of γ-ray irradiation by metallothionein induction by bismuth subnitrate in mice. Eur. J. Cancer Clin. Oncol., 25, 1727-1731 (1989).
21. Satoh, M., Kloth, D. M., Kadhim, S. A., Chin, J. L. Naganuma, A., Imura, N. and Cherian, M. G. Modulation of both cisplatin nephrotoxicity and drug resistance in murine bladder tumor by controlling metallothionein synthesis. Cancer Res., 53, 1829-1832 (1993).
22. Endresen, L., Schjerven, L. and Rugstad, H. E. Tumors from a cell strain with a high content of metallothionein show enhanced resistance against cis-dichlorodiammineplatinum. Acta Pharmacol. Toxicol., 55, 183-187 (1984).
23. Bakka, A., Endresen, L., Johnsen, A. B. S., Edminson, P. D. and Rugstad, H. E. Resistance against cis-dichlorodiammineplatinum in cultured cells with a high content of metallothionein. Toxicol. Appl. Pharmacol., 61, 215-226 (1981).
24. Kasahara, K., Fujiwara, Y., Nishino, K., Ohmori, T., Sugimoto, Y., Komiya, K., Matuda, T. and Saijo, N. Metallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin. Cancer Res., 51, 3237-3242 (1991).
25. Andrews, P. A., Murphy, M. P. and Howell, S. B. Metallothionein-mediated cisplatin resistance in human ovarian carcinoma cells. Cancer Chemother. Pharmacol., 19, 149-154 (1987).
26. Lohrer, H. and Robson, T. Overexpression of metallothionein in CHO cells and its effect on cell killing by ionizing radiation and alkylating agents. Carcinogenesis. 10, 2279-2284 (1989).
27. Kelley, S. L., Basu, A., Teicher, B. A., Hacker, M. P., Hamer, D. H. and Lazo, J. S. Overexpression of metallothionein confers resistance to anticancer drugs. Science, 241, 1813-1815 (1988).
28. Kaina, B., Lohrer, H., Karin, M. and Herrlich, P. Overexpressed human metallothionein IIA gene protects Chinese hamster ovary cells from killing by alkylating agents. Proc. Natl. Acad. Sci. USA, 87, 2710-2714 (1990).
29. Lohrer, H., Robson, T., Grindley, H., Foster, S. and Hall, A. Differential effects on cell killing in metallothionein overexpressing CHO mutant cell lines. Carcinogenesis, 11, 1937-1941 (1990).
30. Schilder, R. J., Hall, L. Monks, A., Handel, L. M., Fornace, A. J. J., Ozols, R. F., Fojo, A. T. and Hamilton, T. C. Metallothionein gene expression and resistance to cisplatin in human ovarian cancer. Int. J. Cancer, 45, 416-422 (1990).
31. Koropatnick, J. and Pearson, J. Altered cisplatin and cadmium resistance and cell survival in Chinese hamster ovary cells expressing mouse metallothionein. Mol. Pharmacol., 44, 44-50 (1993).
32. Minamino, T., Nomura, M., Tamai, M., Moritani, S., Ohshima, T. and Miyamoto, K. In vivo cisplatin resistance of rat ascites hepatoma AH66. Cancer Lett., 108, 153-156 (1996).
33. Durnam, D. M., Perrin, F., Gannon, F. and Palmiter, R. D. Isolation and characterization of the mouse metallothionein-I gene. Proc. Natl. Acad Sci. USA, 77, 6511-6515 (1980).
34. Gorman, C. High-efficiency gene transfer into mammalian cells. In "DNA Cloning - A Practical Approach," ed. D. M. Glover, pp. 143-190 (1985). IRL Press, Oxford.
35. Chen, C. and Okayama, H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol., 7, 2745-2752 (1987).
36. Mulligan, R. C. and Berg, P. Selection for animal cells that express the Escherichia coli gene coding for xanthine-guanine phosphoribosyltransferase. Proc. Natl. Acad. Sci. USA, 78, 2072-2076 (1981).
37. Maniatis, T., Fritsch, E. F. and Sambrook, J. "Molecular Cloning: A Laboratory Manual" (1982). Cold Spring Harbor Laboratory, New York.
38. Davis, L. G., Dibner, M. D. and Battey, J. F. Formaldehyde gel for electrophoretic separation of RNA and Northern blot. In "Basic Methods in Molecular Biology." ed. L. G. Davis, M. D. Dibner and J. F. Battey, pp. 143-146 (1986). Elsevier, New York.
39. Niks, M. and Otto, M. Towards an optimized MTT assay. J. Immunol. Methods. 130, 149-151 (1990).
40. Toyo'oka, T. and Imai, K. High-performance liquid chromatography and fluorometric detection of biologically important thiols, derivatized with ammonium 7-fluorobenzo-2-oxa-1,3-diazole-4-sulphonate (SBD-F). J. Chromatogr., 282, 495-500 (1983).
41. Kotsonis, F. N. and Klaassen, C. D. Comparison of methods for estimating hepatic metallothionein in rats. Toxicol. Appl. Pharmacol., 42, 583-588 (1977).
42. Wheeler, C. R., Salzman, J. A., Elsayed, N. M., Omaye, S. T. and Korte, D. W. J. Automated assay for superoxide dismutase, catalase, glutathione peroxidase, and glutathione reductase activity. Anal. Biochem., 184, 193-199 (1990).
43. Imanari, T., Hirota, M., Miyazaki, M., Hayakawa, K. and Tamura, Z. Improved assay method for superoxide dismutase. J. Clin. Exp. Med., 101, 496-497 (1977).
44. Lowry, O. H., Rosebrough, N. J., Farr, A. L. and Randall, R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193, 265-275 (1951).
45. Ovejera, A. A., Houchens, D. P. and Barker, A. D. Chemotherapy of human tumor xenografts in genetically athymic mice. Ann. Clin. Lab. Sci., 8, 50 (1978).
46. Mulligan, R. C. and Berg, P. Expression of a bacterial gene in mammalian cell. Science, 209, 1422-1427 (1980).